HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $44,646 | +158.4% | 57,534 | -0.1% | 0.00% | – |
| Q4 2022 | $17,278 | -40.4% | 57,594 | +0.1% | 0.00% | – |
| Q3 2022 | $29,000 | -12.1% | 57,534 | 0.0% | 0.00% | – |
| Q2 2022 | $33,000 | -55.4% | 57,534 | 0.0% | 0.00% | – |
| Q1 2022 | $74,000 | +12.1% | 57,534 | 0.0% | 0.00% | – |
| Q4 2021 | $66,000 | +10.0% | 57,534 | +47.4% | 0.00% | – |
| Q3 2021 | $60,000 | – | 39,034 | +134500.0% | 0.00% | – |
| Q3 2019 | $0 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 306,338 | $564,000 | 0.11% |
| PVG ASSET MANAGEMENT CORP | 14,140 | $26,018,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 160,775 | $296,000 | 0.05% |
| Virtu Financial LLC | 179,030 | $329,000 | 0.02% |
| Allen Capital Group, LLC | 23,685 | $44,000 | 0.01% |
| McAdam, LLC | 36,641 | $67,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $18,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $92,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $28,000 | 0.01% |
| Onex Canada Asset Management Inc. | 40,000 | $74,000 | 0.00% |